General Updates
Deal
Deal value₹7 Cr
Deal vs businessSolar capex = ₹6.97 Cr (~3.7% of TTM revenue ₹188 Cr); Q1 FY27 revenue = ₹140.87 Cr
Size vs own revenue0.04×
Execution period1.0 yr
Fundamental gradeC
AI projections
Revenue uplift (yr1 / steady)0.0% / 0.0%
EPS uplift15.0%
Upside base / bull / bear25.0% / 50.0% / -25.0%
Horizon12-24 months
Realized market record
Entry — next-day open (13 Aug 2026)₹296.12
Latest close (16 Oct 2026)₹417.95
Return since+41.1%
α vs Smallcap 250+45.2%
Positives
- Q1 FY27 revenue grew 45.3% YoY to ₹140.87 Cr, signaling top-line demand recovery.
- Commissioning of 2.40 MWp captive solar plant (₹6.97 Cr investment) will reduce operational power costs by ~₹2 Cr annually.
- Promoter holding remains stable at 62.7% with reasonable leverage (D/E of 0.41).
Risks
- Q1 FY27 PAT of ₹15.21 Cr was heavily boosted by a positive inventory swing of ₹20.97 Cr, masking core operating performance.
- Weak underlying historical return ratios with trailing ROCE at 0.0% and an annual net loss in FY26.
- High vulnerability to chemical/raw material price softening and end-user demand slowdowns.
Full AI brief
Analyst Assessment: AksharChem (I) Limited
1. Q1 FY27 Earnings Dissection & Solar Capex Impact
- Q1 FY27 Revenue: ₹140.87 Cr (+45.3% YoY vs ₹96.96 Cr in Q1 FY26).
- Q1 FY27 Reported PAT: ₹15.21 Cr (EPS ₹18.94) compared to ₹0.71 Cr in Q1 FY26.
- Critical Accounting Context: The earnings surge was significantly aided by a ₹20.97 Cr positive inventory credit swing. Excluding this non-operational inventory adjustment, core operating profitability remains much lower.
- Solar Plant Capex: Commissioned a 2.40 MWp (DC) ground-mounted solar power plant on April 24, 2026, for ₹6.97 Cr (~3.7% of TTM revenue). Assuming ~3.6 million kWh generated per year with savings of ~₹5.5-6.0 per unit, total power cost savings will be ~₹2.0-2.2 Cr annually. This lifts steady-state EPS by ~₹2.50 (~15% uplift on base earnings), but does not add direct top-line revenue.
2. Industry Dynamics & Fundamentals
- Capital Intensity: Medium. Dyes and pigments require continuous maintenance capex and power cost optimizations.
- Industry Growth: Structural industry CAGR is estimated at ~7-8%.
- Quality & Margin Profile: The company suffered a full-year net loss of ₹0.44 Cr in FY26 despite ₹372 Cr revenue. Trailing ROCE stands at 0.0%, failing the structural quality gate. Pricing power is weak due to international dye price softening.
3. Valuation & Scenarios
- Current Valuation: Price ₹282.0, Market Cap ₹197 Cr, P/E context 22.2x vs peer median of 18.5x.
- Base Case (+25% Upside): Operations normalize, solar cost savings add ~₹2 Cr to annual PAT, normalized annual EPS reaches ₹22-25 (ex-inventory swings), P/E moderates to ~13-14x.
- Bull Case (+50% Upside): Sustained volume utilization in Precipitated Silica and Pigment Green 7 drives FY27 revenue >₹500 Cr with sustainable core OPM >14%, driving annual core EPS to ₹32+.
- Bear Case (-25% Downside): Inventory gains reverse in H2 FY27, raw material cost pressures resume, pushing margins back near break-even levels.
4. Conclusion & Verdict
While the Q1 FY27 headline profits look impressive (EPS ₹18.94), over 100% of the net profit spike is attributable to inventory accounting adjustments. Combined with zero trailing ROCE and cyclical sector headwinds, AksharChem is classified as UNLIKELY to deliver multi-bagger performance without sustained non-inventory core execution.
Analysis as of 2026-08-12 (price ₹282.02) ·
AI research, not investment advice.
FollowTelegram
